Dr. Spencer Kalman Koerner, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 8700 Beverly Blvd, East 245, West Hollywood, CA 90048 Phone: 310-423-7890 Fax: 310-423-0166 |
Daniel Tabari, Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd # 5512, West Hollywood, CA 90048 Phone: 818-642-3141 |
Tanzira Zaman, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-423-0989 Fax: 310-423-0129 |
Dr. Sara Ghandehari, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd, Rm 6732, West Hollywood, CA 90048 Phone: 310-423-4685 |
Anna Skor Noble, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd, West Hollywood, CA 90048 Phone: 310-423-5386 |
Oragun Karla Rojanapairat, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8700 Beverly Blvd Rm 6735, West Hollywood, CA 90048 Phone: 310-423-1838 |
News Archive
Eating dark chocolate on a daily basis appears to decrease risk for cardiovascular events in patients with the metabolic syndrome, say researchers.
For the fifth year in a row, HealthPlus of Michigan's commercial and Medicare Advantage health plans are recognized by U.S. News & World Report/NCQA as among the nation's best.
Current treatments for anorexia and bulimia nervosa, which afflict an estimated 10 to 24 million Americans, are often limited and ineffective.
The negative health effects of early-life exposure to secondhand smoke appear to impact girls more than boys-particularly those with early-life allergic sensitization, according to new research from the University of Cincinnati (UC) College of Medicine.
Emdeon Inc. opened for trading today on the New York Stock Exchange under the ticker symbol "EM" after its successful initial public offering in which it raised $367 million in gross proceeds. Headquartered in Nashville, Tenn., Emdeon is the 13th IPO by an operating company, including non-U.S. companies, and the 10th U.S. domestic IPO to list on the New York Stock Exchange this year.
› Verified 8 days ago